Maseri A. Ischemic Heart Disease, 1995. New York: Churchill Livingstone Inc.
Virmani R., Forman M.B. Nonatherosclerotic Ischemic Heart Disease, 1988. New York: Raven Press.
Camici P.G., Crea F. Coronary microvascular dysfunction // N. Engl. J. Med. - 2007. - Vol. 356. - P. 830840.
Klassen G.A., Armour J.A., Garner J.B. Coronary circulatory pressure gradient // Can. J. Physiol. Pharmacol. - 1987. - Vol. 65. - P. 520-531.
Dunker D.J., Ishibashi Y., Bache R.J. Effect of treadmill exercise on transmural distribution of blood flow in hypertrophied left ventricle // Am. J. Physiol. - 1998. - Vol. 275. - P. 1274-1282.
Feigl E.O. The paradox of adrenergic coronary vasoconstriction // Circulation. - 1987. - Vol. 76. - P. 737745.
Crea F., Gaspardone A., Araujo L. et al. Effects of aminophylline on cardiac function and regional myocardial perfusion: implication regarding its antiischemic action // Am. Heart J. - 1994. - Vol. 127. - P. 817-824.
Lupi A., Buffon A., Finocchiaro M.L. et al. Mechanisms of adenosine-induced epicardial coronary artery dilatation // Eur. Heart J. - 1997. - Vol. 18. - P. 614-617.
Jones C.J.H, Kuo L., Davies M.J. et al. Regulation of coronary blood flow: coordination of heterogeneous control mechanisms in vascular microdomains // Cardiovasc. Res. - 1995. - Vol. 29. - P. 585-596.
Duffy S.J., Castle S.F., Harper R.W. et al. Contribution of vasodilator prostanoids and nitric oxide to resting flow, metabolic vasodilation, and flow-mediated dilation in human coronary circulation // Circulation. - 1999. - Vol. 100. - P. 1951-1957.
Vanhoutte P.M. Endothelial control of vasomotor function: from health to coronary disease // Circ. J. - 2003. - Vol. 67. - P. 572-575.
FitzGerald G.A., Smith B., Pedersen A.K. et al. Increased prostacyclin biosynthesis in patients with severe atherosclerosis and platelet activation // N. Engl. J. Med. - 1984. - Vol. 310. - P. 1065-1068.
Brunner H., Cockcroft J.R., Deanfield J. et al. Endothelial function and dysfunction. Part II: association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension // J. Hypertens. - 2005. - Vol. 23. - P. 233246.
Kuo L., Chilian W.M., Davis M.J. Coronary arteriolar myogenic response is independent of endothelium // Circ. Res. - 1990. - Vol. 66. - P. 860-866.
Davis M.J., Donovitz J.A., Hood J.D. Stretch-activated single-channel and whole cell currents in vascular smooth muscle cells // Am. J. Physiol. - 1992. - Vol. 262. - P. 1083-1088.
Camici P.G., Marraccini P., Marzilli M. et al. Coronary hemodynamics and myocardial metabolism during and after pacing stress in normal humans // Am. J. Physiol. - 1989. - Vol. 257: E309-E317.
Heusch G., Baumgart D., Camici P. et al. Alpha-adrenergic coronary vasoconstriction and myocardial ischemia in humans // Circulation. - 2000. - Vol. 101. - P. 689-694.
Braunwald E. Control of myocardial oxygen consumption: physiologic and clinical considerations // Am. J. Cardiol. - 1971. - Vol. 27. - P. 416-432.
Belardinelli L., Linden J., Berne R.M. The cardiac effects of adenosine // Prog. Cardiovasc. Dis. - 1989. - Vol. 32. - P. 73-97.
Chilian W.M. Coronary microcirculation in health and disease. Summary of an NHLBI workshop // Circulation. - 1997. - Vol. 95. - P. 522-528.
Olsson R.A., Gregg D.E. Myocardial reactive hyperemia in the unanesthetized dog // Am. J. Physiol. - 1965. - Vol. 208. - P. 224-230.
Kelley K.O., Gould, K.L. Coronary reactive hyperaemia after brief occlusion and after deoxygenated perfusion // Cardiovasc. Res. - 1981. - Vol. 15. - P. 615-622.
L’Abbate A., Camici P., Trivella M.G. et al. Time-dependent response of coronary flow to prolonged adenosine infusion: doubling of peak reactive hyperaemic flow // Cardiovasc. Res. - 1981. - Vol. 15. - P. 282-286.
Lorenzoni R., Rosen S.D., Camici P.G. Effect of alpha-1. adrenoceptor blockade on resting and hyperemic myocardial blood flow in normal humans // Am. J. Physiol. - 1996. - Vol. 271. - P. H1302- H1306.
Meredith I.T., Currie K.E., Anderson T.J. et al. Postischemic vasodilation in human forearm is dependent on endothelium-derived nitric oxide // Am. J. Physiol. - 1996. - Vol. 270. - P. 1435-1440.
Gould K.L., Lipscomb K., Hamilton G.W. Physiologic basis for assessing critical coronary stenosis. Instantaneous flow response and regional distribution during coronary hyperemia as measures of coronary flow reserve // Am. J. Cardiol. - 1974. - Vol. Vol. 33. - P. 87-94.
Hoffman J.I. A critical review of coronary reserve // Circulation. - 1987. - Vol. 75. - P. 6-11.
Bache R.J., Vrobel T.R., Arentzen C.E. et al. Effect of maximal coronary vasodilation on transmural myocardial perfusion during tachycardia in dogs with left ventricular hypertrophy // Circ. Res. - 1981. - Vol. 49. - P. 742-749.
Chareonthaitawee P., Kaufmann P.A., Rimoldi O. et al. Heterogeneity of resting and hyperemic myocardial blood flow in healthy humans // Cardiovasc. Res. - 2001. - Vol. 50. - P. 151-161.
Uren N.G., Camici P.G., Melin J.A. et al. The effect of aging on the coronary vasodilator reserve in man // J. Nucl. Med. - 1995. - Vol. 36. - P. 2032-2036.
Marcus M.L., Wilson R.F., White C.W. Methods of measurement of myocardial blood flow in patients: a critical review // Circulation. - 1987. - Vol. 76. - P. 245-253.
Jenni R., Matthews F., Aschkenasy S.V. et al. A novel in vivo procedure for volumetric flow measurements // Ultrasound Med. Biol. - 2004. - Vol. 30. - P. 633-637.
Ito Y., Katoh C., Noriyasu K. et al. Estimation of myocardial blood flow and myocardial flow reserve by 99mTc-sestamibi imaging: comparison with the results of H2O PET // Eur. J. Nucl. Med. Mol. Imaging. - 2003. - Vol. 30. - P. 281-287.
Camici P.G., Rosen S.D., Spinks T.J. et al. Positron emission tomography. In Ell PJ, Gambhir SS (eds.) Nuclear Medicine in Clinical Diagnosis and Treatment, 2004. London: Churchill-Livingstone. - P. 10751091.
Chilian W.M., Layne S.M., Klausner E.C. et al. Redistribution of coronary microvascular resistance produced by dypiridamole // Am. J. Physiol. - 1989. - Vol. 256. - P. 383-392.
Uren N.G., Melin J.A., Bruyne B. et al. Relation between myocardial blood flow and the severity of coronary-artery stenosis // N. Engl. J. Med. - 1994. - Vol. 330. - P. 1782-1788.
Lanza G.A., Cianflone D., Coli S. et al. Coronary blood flow and myocardial ischemia. In Fuster V, Alexander R.W., O’Rourke R.A. Hurst’s The Heart, 2004. New York: mcGraw-Hill, pp.1153-1172.
Lanza, G.A., Maseri A. Diagnosis and treatment of coronary artery spasm // Cardiol. Rev. - 1996. - Vol. 1. - P. 1-6.
Kaski J.C., Crea F., Meran D. et al. Local coronary supersensitivity to diverse vasoconstrictive stimuli in patients with variant angina // Circulation. - 1986. - Vol. 74. - P. 1255-1265.
Lanza G.A., Pedrotti P., Pasceri V. et al. Autonomic changes associated with spontaneous coronary spasm in patients with variant angina // J. Am. Coll. Cardiol. - 1996. - Vol. 28. - P. 1249-1256.
Masumoto A., Mohri M., Shimokawa H. et al. Suppression of coronary artery spasm by the Rho-kinase inhibitor fasudil in patients with vasospastic angina // Circulation. - 2002. - Vol. 105. - P. 1545-1547.
Chutkow W.A., Pu J., Wheeler M.T. et al. Episodic coronary artery vasospasm and hypertension develop in the absence of Sur2. K(ATP) channels // J. Clin. Invest. - 2002. - Vol. 110. - P. 203-208.
Lanza G.A., Candia E., Romagnoli E. et al. Increased platelet sodium-hydrogen exchanger activity in patients with variant angina // Heart. - 2003. - Vol. 89. - P. 935-936.
Maseri A., Davies G., Hackett D. et al. Coronary artery spasm and coronary vasoconstriction: the case for a distinction // Circulation. - 1990. - Vol. 81. - P. 1983-1991.
Mongiardo R., Finocchiaro M.L., Beltrame J. et al. Low incidence of serotonin-induced occlusive coronary artery spasm in patients with recent myocardial infarction // Am. J. Cardiol. - 1996. - Vol. 78. - P. 84-87.
Britten M.B., Zeiher A.M., Schachinger V. Microvascular dysfunction in angiographically normal or mildly diseased coronary arteries predicts adverse cardiovascular long-term outcome // Cor. Art. Dis. - 2004. - Vol. 15. - P. 259-264.
Wiernsperger N.F., Bouskela E. Microcirculation in insulin resistance and diabetes: more than just a complication // Diabetes Metab. - 2003. - Vol. 29: S77-S87.
Kaufmann P.A., Gnecchi-Ruscone T., Schafers K.P. et al. Low density lipoprotein cholesterol and coronary microvascular dysfunction in hypercholesterolemia // J. Am. Coll. Cardiol. - 2000. - Vol. 36. - P. 103-109.
Jongh R.T., Serne E.H., Izerman R.G. et al. Impaired microvascular function in obesity: implications for obesity-associated microangiopathy, hypertension, and insulin resistance // Circulation. - 2004. - Vol. 109. - P. 2529-2535.
Ijzerman R.G., Serne E.H., Weissenbruch M.M. et al. Cigarette smoking is associated with an acute impairment of microvascular function in humans // Clin. Sci. - 2003. - Vol. 104. - P. 247-252.
Prati F., Pawlowski T., Gil R. et al. Stenting of culprit lesions in unstable angina leads to a marked reduction in plaque burden: a major role of plaque embolization? A serial intravascular ultrasound study // Circulation. - 2003. - Vol. 107. - P. 2320-2325.
Heusch G., Schulz R., Haude M. et al. Coronary microembolization // J. Mol. Cell. Cardiol. - 2004. - Vol. 37. - P. 23-31.
Galiuto L., Lombardo A., Maseri A. et al. Temporal evolution and functional outcome of no reflow: sustained and spontaneously reversible patterns following successful coronary recanalisation // Heart. - 2003. - Vol. 89. - P. 731-737.
Neglia D., Michelassi C., Trivieri M.G. et al. Prognostic role of myocardial blood flow impairment in idiopathic left ventricular dysfunction // Circulation. - 2002. - Vol. 105. - P. 186-193.
Cecchi F., Olivotto I., Gistri R. et al. Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy // N. Engl. J. Med. - 2003. - Vol. 349. - P. 1027-1035.
Kao C.H., Wang S.J., Ting C.T. et al. Tc-99m sestamibi myocardial SPECT in syndrome X // Clin. Nucl. Med. - 1996. - Vol. 21. - P. 280-283.
Chauhan A., Mullins P.A., Taylor G. et al. Both endothelium-dependent and endothelium-independent function is impaired in patients with angina pectoris and normal coronary angiograms // Eur. Heart J. -
- Vol. 18. - P. 60-68.
Buffon A., Rigattieri S., Santini S.A. et al. Myocardial ischemia-reperfusion damage after pacing-induced tachycardia in patients with cardiac syndrome X // Am. J. Physiol. - 2000. - Vol. 279. - P. H2627-H2633.
Rosen S.D., Uren N.G., Kaski J.C. et al. Coronary vasodilator reserve, pain perception and gender in patients with syndrome X // Circulation. - 1994. - Vol. 90. - P. 50-60.
Camici P.G., Marraccini P., Lorenzoni R. et al. Coronary hemodynamics and myocardial metabolism in patients with syndrome X: response to pacing stress // J. Am. Coll. Cardiol. - 1991. - Vol. 17. - P. 14611470.
Cannon R.O., Camici P.G., Epstein S.E. Pathophysiological dilemma of syndrome X // Circulation. -
- Vol. 85. - P. 883-892.
Maseri A., Crea F., Kaski J.C. et al. Mechanisms of angina pectoris in syndrome X // J. Am. Col.
Cardiol. - 1991. - Vol. 17. - P. 499-506.
Reimer K.A., Jennings R. Myocardial ischemia, hypoxia and infarction. In Fozzard H.A. et al. (eds.) The Heart and Cardiovascular System, 1992. New York: Raven Press Ltd. - P. 1875-1973.
Abbate A., Biondi-Zoccai G.G., Bussani R. et al. Increased myocardial apoptosis in patients with unfavourable left ventricular remodeling and early symptomatic post-infarction heart failure // J. Am. Coll. Cardiol. - 2003. - Vol. 41. - P. 753-760.
Camici P.G., Ferrannini E., Opie L.H. Myocardial metabolism in ischemic heart disease: basic principles and application to imaging by positron emission tomography // Prog. Cardiovasc. Dis. - 1989. - Vol. 32. - P. 217-238.
Camici P.G., Araujo L., Spinks T. et al. Increased uptake of 18F-fluorodeoxyglucose in postischemic myocardium of patients with exercise-induced angina // Circulation. - 1986. - Vol. 74. - P. 81-88.
Tennant R., Wiggers C.J. Effect of coronary occlusion on myocardial contraction // Am. J. Physiol. - 1935. - Vol. 112. - P. 351-361.
Heyndrickx G.R., Millard R.W., McRitchie R.J. et al. Regional myocardial functional and electrophysiological alterations after brief coronary artery occlusion in conscious dogs // J. Clin. Invest. - 1975. - Vol. Vol. 56. - P. 978-985.
Barnes E., Hall R.J., Dutka D.P. et al. Absolute blood flow and oxygen consumption in stunned myocardium in patients with coronary artery disease // J. Am. Coll. Cardiol. - 2002. - Vol. 39. - P. 420-427.
Ambrosio G., Betocchi S., Pace L. et al. Prolonged impairment of regional contractile function after resolution of exercise-induced angina. Evidence of myocardial stunning in patients with coronary artery disease // Circulation. - 1996. - Vol. 94. - P. 2455-2464.
Wijns W., Vatner S.F., Camici P.G. Mechanisms of disease hibernating myocardium // N. Engl. J. Med. -
- Vol. 339. - P. 173-181.
Murry C.E., Jenning R.B., Reimer K.A. Preconditioning with ischemia a delay of lethal cell injury in ischemic myocardium // Circulation. - 1986. - Vol. 74. - P. 1124-1136.
Baxter G.F., Marber M.S., Patel V.C. et al. Adenosine receptor involvement in a delayed phase of myocardial protection 24. hours after ischemic preconditioning // Circulation. - 1994. - Vol. 90. - P. 29933000.
Tomai F., Crea F., Chiariello L. et al. Ischemic preconditioning in humans: models, mediators, and clinical relevance // Circulation. - 1999. - Vol. 100. - P. 559-563.
Spyrou N., Rosen S.D., Fath-Ordoubadi F. et al. Myocardial р-adrenoceptor density one month after acute myocardial infarction predicts left ventricular volumes at six months // J. Am. Coll. Cardiol. - 2002. - Vol. 40. - P. 1216-1224.
Heberden W. Some account of a disorder of the breast // Med. Trans - 1772. - Vol. 2. - P. 59-67.
Sylven C., Beermann B., Jonzon B. et al. Angina pectoris-like pain provoked by intravenous adenosine in healthy volunteers // Br. Med. J. - 1986. - Vol. 293. - P. 227-230.
Crea F, Pupita G, Galassi AR, et al. Role of adenosine in pathogenesis of anginal pain // Circulation. -
- Vol. 81. - P. 164-172.
Rosen S.D., Paulesu E., Frith C.D. et al. Central nervous pathways mediating angina pectoris // Lancet. -
- Vol. 344. - P. 147-150.
Melzack R, Wall PD. Pain mechanisms: a new theory // Science. - 1965. - Vol. 150. - P. 971-99.
Pasceri V., Cianflone D., Finocchiaro M.L. et al. Relation between myocardial infarction site and pain location in Q wave acute myocardial infarction // Am. J. Cardiol. - 1995. - Vol. 75. - P. 224-230.
Crea F., Gaspardone A., Kaski J.C. et al. Relation between stimulation site of cardiac afferent nerves by adenosine and location of cardiac pain in patients with stable angina // J. Am. Coll. Cardiol. - 1992. - Vol. 20. - P. 1498-1502.
Pasceri V., Patti G., Maseri A. Changing features of anginal pain after PTCA suggest a stenosis on a different artery rather than restenosis // Circulation. - 1997. - Vol. 96. - P. 3278-3283.
Schaper W., Gorge G., Winkler B. et al. The collateral circulation of the heart // Prog. Cardiovasc. Dis. - 1988. - Vol. 31. - P. 57-77.
Pepper M.S. Manipulating angiogenesis. From basic science to the bedside // Arterioscl. Vasc. Thromb. -
- Vol. 17. - P. 605-619.
Schaper W., Ito W.D. Molecular mechanisms of coronary collateral vessel growth // Circ. Res. - 1996. - Vol. 79. - P. 911-919.
Isner J.M., Asahara T. Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization // J. Clin. Invest. - 1999. - Vol. 103. - P. 1231-1236.
Ford E.S., Ajani U.A., Croft J.B. et al. Explaining the Decrease in U.S. Deaths from Coronary Disease, 1980-2000 // N. Engl. J. Med. - 2007. - Vol. 356. - P. 2388-2398.
Krogh V., Trevisan M., Panico . et al. Prevalence and correlates of angina pectoris in the Italian nine communities study. Research Group ATS-RF2. of the Italian National Research Council // Epidemiology. -
- Vol. 2. - P. 26-32.
Ford ES, Giles WH, Croft JB. Prevalence of nonfatal coronary heart disease among American adults // Am. Heart J. - 2000. - Vol. 139. - P. 371-377.
Wannamethee G., Shaper A.G., MacFarlane P.W. Using the WHO (Rose) angina questionnaire in cardiovascular epidemiology // Int. J. Epidemiol. - 1989. - Vol. 18. - P. 607-613.
Ducimetiere P., Ruidavets J.B., Montaye M. et al. PRIME Study Group. Five-year incidence of angina pectoris and other forms of coronary heart disease in healthy men aged 50-59. in France and Northern Ireland: the Prospective Epidemiological Study of Myocardial Infarction (PRIME) Study // Int. J.
Epidemiol. - 2001. - Vol. 30. - P. 1057-1062.
Tunstall-Pedoe H., Kuulasmaa K., Mahonen M. et al. Contribution of trends in survival and coronary- event rates to changes in coronary heart disease mortality. - P. 10-year results from 37. WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease // Lancet. - 1999. - Vol. 353. - P. 1547-1557.
Hemingway H., Langenberg C., Damant J. et al. Prevalence of angina in women versus men: a systematic review and meta-analysis of international variations across 31. countries // Circulation. - 2008. - Vol. 117. - P. 1526-1536.
Crea F., Lanza G.A. Angina pectoris and normal coronary arteries: cardiac syndrome X // Heart. - 2004. - Vol. 90. - P. 457-463.
Johnson B.D., Shaw L.J., Buchthal S.D. et al. National Institutes of Health-National Heart, Lung, and Blood Institute. Prognosis in women with myocardial ischemia in the absence of obstructive coronary disease: results from the National Institutes of Health-National Heart, Lung, and Blood Institute- Sponsored Women’s Ischemia Syndrome Evaluation (WISE) // Circulation. - 2004. - Vol. 109. - P. 29932999.
Lanza G.A. Cardiac syndrome X: a critical overview and future perspectives // Heart. - 2007. - Vol. 93. - P. 159-166.
Kannel W.B., Feinleib M. Natural history of angina in the Framingham study // Am. J. Cardiol. - 1972. - Vol. 29. - P. 154-165.
Maggioni A., Maseri A., Fresco C. Age-related increase in mortality among patients with first myocardial infarctions treated with thrombolysis. The Investigators of the Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico (GISSI-2) // N. Engl. J. Med. - 1993. - Vol. 329. - P. 1442-1448.
Crea F., Gaspardone A. New look to an old symptom: angina pectoris // Circulation. - 1997. - Vol. 96. - P. 3766-3773.
Lanza G.A., Sciahbasi A., Sestito A. et al. Angina pectoris: a headache // Lancet. - 2000. - Vol. 356. - P. 998.
Fox K., Garcia M.A., Ardissino D. et al. Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology // Eur. Heart J 27. - P. 1341-1381.
Versaci F., Gaspardone A., Tomai F. et al. Chest pain after coronary artery stent implantation // Am. J. Cardiol. - 2002. - Vol. 89. - P. 500-504.
Candell-Riera J., Gordillo E., Oller-Martinez G. et al. Long-term outcome of painful left bundle branch block // Am. J. Cardiol. - 2002. - Vol. 89. - P. 602-604.
Cohn P.F., Fox K.M., Daly C. Silent Myocardial Ischemia // Circulation. - 2003. - Vol. 108. - P. 1263-1277.
Rosen S.D., Paulesu E., Nihoyannopoulos P. et al. Silent ischemia as a central problem: regional brain activation compared in silent and painful myocardial ischemia // Ann. Intern. Med. - 1996. - Vol. 124. - P. 939-949.
Nesto R.W., Phillips R.T., Kett K.G. et al. Angina and exertional myocardial ischemia in diabetic and nondiabetic patients: assessment by exercise thallium scintigraphy // Ann. Intern. Med. - 1988. - Vol. 108. - P. 170-175.
Caracciolo E.A., Chaitman B.R., Forman S.A. et al. Diabetics with coronary artery disease have a prevalence of asymptomatic ischemia during exercise treadmill testing and ambulatory ischemia monitoring similar to that of nondiabetic patients: an ACIP database study // Circulation. - 1996. - Vol. 93. - P. 2097-2105.
Rutter M.K., Wahid S.T., McComb J.M. et al. Significance of silent ischemia and microalbuminuria in predicting coronary events in asymptomatic patients with type 2. diabetes // J. Am. Coll. Cardiol. - 2002. - Vol. 40. - P. 56-61.
Kaski J.C., Tousoulis D., Haider A.W. et al. Reactivity of eccentric and concentric coronary stenoses in patients with chronic stable angina // J. Am. Coll. Cardiol. - 1991. - Vol. 17. - P. 627-633.
Pupita G.S., Maseri A., Kaski J.C. et al. Myocardial ischemia caused by distal coronary artery constriction in stable angina pectoris // New Engl. J. Med. - 1990. - Vol. 323. - P. 514-520.
Campeau L. Grading of angina pectoris // Circulation. - 1976. - Vol. 54. - P. 522.
Hlatky M.A., Boineau R.E., Higginbotham M.B. et al. A brief self-administered questionnaire to determine functional capacity (the Duke Activity Status Index) // Am. J. Cardiol. - 1989. - Vol. 64. - P. 651-654.
Spertus J.A., Winder J.A., Dewhurst T.A. et al. Development and evaluation of the Seattle Angina Questionnaire: a new functional status measure for coronary artery disease // J. Am. Coll. Cardiol. - 1995. - Vol. 25. - P. 333-341.
Spertus J.A., Jones P., McDonell M. et al. Health status predicts long-term outcome in outpatients with coronary disease // Circulation. - 2002. - Vol. 106. - P. 43-49.
Margolis J.R., Chen J.T., Kong Y. et al. The diagnostic and prognostic significance of coronary artery calcification. A report of 800 cases // Radiology. - 1980. - Vol. 137. - P. 609-616.
Gill J.B., Cairns J.A., Roberts R.S. et al. Prognostic importance of myocardial ischemia detected by ambulatory monitoring early after acute myocardial infarction // N. Engl. J. Med. - 1996. - Vol. 334. - P. 65-70.
Wolf E., Tzivoni D., Stern S. Comparison of exercise tests and 24-hour ambulatory electrocardiographic monitoring in detection of ST-T changes // Br. Heart J. - 1974. - Vol. Vol. 36. - P. 90-95.
Barnabei L., Marazia S., De Caterina R. Receiver operating characteristic (ROC) curves and the definition of threshold levels to diagnose coronary artery disease on electrocardiographic stress testing. Part I: The use of ROC curves in diagnostic medicine and electrocardiographic markers of ischaemia // J.
Cardiovasc. Med. (Hagerstown). - 2007. - Vol. 8. - P. 873-881.
Lanza G.A., Mustilli M., Sestito A. et al. Diagnostic and prognostic value of ST segment depression limited to the recovery phase of exercise stress test // Heart. - 2004. - Vol. 90. - P. 1417-1421.
Hung J., Chaitman B.R., Lam J. et al. A logistic regression analysis of multiple noninvasive tests for the prediction of the presence and extent of coronary artery disease in men // Am. Heart J. - 1985. - Vol. 110. - P. 460-469.
Gibson R.S. The diagnostic and prognostic value of exercise electrocardiography in asymptomatic subjects and stable symptomatic patients // Curr. Opin. Cardiol. - 1991. - Vol. 6. - P. 536-546.
Kwok Y., Kim C., Grady D. et al. Meta-analysis of exercise testing to detect coronary artery disease in women // Am. J. Cardiol. - 1999. - Vol. 83. - P. 660-666.
Gibbons R.J., Chatterjee K., Daley J. et al. ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina // J. Am. Coll. Cardiol. - 1999. - Vol. 33. - P. 2092-2097.
Ribisl P.M., Morris C.K., Kawaguchi T. et al. Angiographic patterns and severe coronary artery disease. Exercise test correlates // Arch. Intern. Med. - 1992. - Vol. 152. - P. 1618-1624.
Gibbons R.J., Balady G.J., Beasley J.W. et al. ACC/AHA guidelines for exercise testing. executive summary // Circulation. - 1997. - Vol. 96. - P. 345-354.
Marazia S., Barnabei L., De Caterina R. Receiver operating characteristic (ROC) curves and the definition of threshold levels to diagnose coronary artery disease on electrocardiographic stress testing. Part II: the use of ROC curves in the choice of electrocardiographic stress test markers of ischaemia // J.
Cardiovasc. Med. (Hagerstown). - 2008. - Vol. 9. - P. 22-31.
Epstein S.E. Implications of probability analysis on the strategy used for noninvasive detection of coronary artery disease. Role of single or combined use of exercise electrocardiographic testing, radionuclide cineangiography and myocardial perfusion imaging // Am. J. Cardiol. - 1980. - Vol. 46. - P. 491-499.
Bogaty P., Dagenais G.R., Cantin B. et al. Prognosis in patients with a strongly positive exercise electrocardiogram // Am. J. Cardiol. - 1989. - Vol. 64. - P. 1284-1288.
Hung J., Chaitman B.R., Lam. J., et al. Noninvasive diagnostic test choices for the evaluation of coronary artery disease in women: a multivariate comparison of cardiac fluoroscopy, exercise electrocardiography and exercise thallium myocardial perfusion scintigraphy // J. Am. Coll. Cardiol. - 1994. - Vol. 4. - P. 8-16.
Gupta N.C., Esterbrooks D.J., Hilleman D.E. et al. Comparison of adenosine and exercise thallium- 201. single-photon emission computed tomography (SPECT) myocardial perfusion imaging. The GE SPECT Multicenter Adenosine Study Group // J. Am. Coll. Cardiol. - 1992. - Vol. 19. - P. 248-257.
Nishimura S., Mahmarian J.J., Boyce T.M. et al. Equivalence between adenosine and exercise thallium- 201. myocardial tomography: a multicenter, prospective, crossover trial // J. Am. Coll. Cardiol. - 1992. - Vol. 20. - P. 265-275.
The American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Clinical Application of Echocardiography) (1997). ACC/AHA Guidelines for the Clinical Application of Echocardiography // Circulation. - 1997. - Vol. 95. - P. 1686-1744.
Dagianti A., Penco M., Agati L. et al. Stress echocardiography: comparison of exercise, dipyridamole and dobutamine in detecting and predicting the extent of coronary artery disease // J. Am. Coll. Cardiol. -
- Vol. 26. - P. 18-25.
Nagel E., Lehmkuhl H.B., Bocksch W. et al. Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: comparison with dobutamine stress echocardiography // Circulation. - 1999. - Vol. 99. - P. 763-770.
Hundley W.G., Morgan T.M., Neagle C.M. et al. Magnetic resonance imaging determination of cardiac prognosis // Circulation. - 2002. - Vol. 106. - P. 2328-2333.
Schwitter J., Nanz D., Kneifel S. et al. Assessment of myocardial perfusion in coronary artery disease by magnetic resonance: a comparison with positron emission tomography and coronary angiography // Circulation. - 2001. - Vol. 103. - P. 2230-2235.
Agatston A.S., Janowitz W.R., Hildner F.J. et al. Quantification of coronary artery calcium using ultrafast computed tomography // J. Am. Coll. Cardiol. - 1990. - Vol. 15. - P. 827-832.
Rumberger J.A., Simons D.B., Fitzpatrick L.A. et al. Coronary artery calcium area by electron-beam computed tomography and coronary atherosclerotic plaque area. A histopathologic correlative study // Circulation. - 1995. - Vol. 92. - P. 2157-2162.
Miller J.M., Rochitte C.E., Dewey M. et al. Diagnostic Performance of Coronary Angiography by 64-Row CT // N. Engl. J. Med. - 2008. - Vol. 359. - P. 2324-2336.
Pennell D.J., Sechtem U.P., Higgins C.B. et al. Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report // Eur. Heart J. - 2004. - Vol. 25. - P. 1940-1965.
Toussaint J.F., LaMuraglia G.M., Southern J.F. et al. Magnetic resonance images lipid, fibrous, calcified, hemorrhagic, and thrombotic components of human atherosclerosis in vivo // Circulation. - 1996. - Vol. 94. - P. 932-938.
Mintz G.S., Nissen S.E., Anderson W.D. et al. American College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS). A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents // J. Am. Coll. Cardiol. - 2001. - Vol. 37. - P. 1478-1492.
Gould K.L., Kirkeeide R.L., Buchi M. Coronary flow reserve as a physiologic measure of stenosis severity // J. Am. Coll. Cardiol. - 1990. - Vol. 15. - P. 459-474.
Di Carli M., Czernin J., Hoh C.K. et al. Relation among stenosis severity, myocardial blood flow, and flow reserve in patients with coronary artery disease // Circulation. - 1995. - Vol. 91. - P. 1944-1951.
Pijls N.H., De Bruyne B., Peels K. et al. Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses // N. Engl. J. Med. - 1996. - Vol. 334. - P. 1703-1708.
Hubbard B.L., Gibbons R.J., Lapeyre A.C 3rd et al. Identification of severe coronary artery disease using simple clinical parameters // Arch. Intern. Med. - 1992. - Vol. 152. - P. 309-312.
Harris P.J., Harrell F.E., Lee K.L. et al. Survival in medically treated coronary artery disease //
Circulation. - 1979. - Vol. 60. - P. 1259-1269.
Califf R.M., Armstrong P.W., Carver J.R. et al. 27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events. Task Force 5: stratification of patients
into high, medium and low risk subgroups for purposes of risk factor management // J. Am. Coll. Cardiol. -
- Vol. 27. - P. 1007-1019.
Daly C.A., De Stavola B., Lopez Sendon J.L. et al. Predicting prognosis in stable angina results from the Euro heart survey of stable angina: prospective observational study // BMJ. - 2006. - Vol. 332. - P. 262267.
Emond M., Mock M.B., Davis K.B. et al. Long-term survival of medically treated patients in the Coronary Artery Surgery Study (CASS) Registry // Circulation. - 1994. - Vol. 90. - P. 2645-2657.
Weiner D.A., Ryan T.J., McCabe C.H. et al. Prognostic importance of a clinical profile and exercise test in medically treated patients with coronary artery disease // J. Am. Coll. Cardiol. - 1984. - Vol. 3. - P. 772779.
Weiner D.A., Ryan T.J., McCabe C.H. et al. Value of exercise testing in determining the risk classification and the response to coronary artery bypass grafting in 3-vessel coronary artery disease: a report from the Coronary Artery Surgery Study (CASS) registry // Am. J. Cardiol. - 1987. - Vol. 60. - P. 262-6.
Mark D.B., Shaw L., Harrell F.E., Jr. et al. Prognostic value of a treadmill exercise score in outpatients with suspected coronary artery disease // N. Engl. J. Med. - 1991. - Vol. 325. - P. 849-853.
Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Radionuclide Imaging), developed in collaboration with the American Society of Nuclear Cardiology. Guidelines for clinical use of cardiac radionuclide imaging. Report of the American College of Cardiology/American Heart Association // J. Am. Coll. Cardiol. - 1995. - Vol. 25. - P. 521-547.
Kotler T.S., Diamond G.A. Exercise thallium-201. scintigraphy in the diagnosis and prognosis of coronary artery disease // Ann. Intern. Med. - 1990. - Vol. 113. - P. 684-702.
Marcovitz P.A., Shayna V., Horn R.A. Value of dobutamine stress echocardiography in determining the prognosis of patients with known or suspected coronary artery disease // Am. J. Cardiol. - 1996. - Vol. 78. - P. 404-408.
Rocco M.B., Nabel E.G., Campbell S. et al. Prognostic importance of myocardial ischemia detected by ambulatory monitoring in patients with stable coronary artery disease // Circulation. - 1988. - Vol. 78. - P. 877-884.
Crea F, Lanza G.A. The elusive link between stenosis severity and prognosis in stable ischaemic heart disease // Heart. - 2003. - Vol. 89. - P. 961-962.
Bigi R., Cortigiani L., Colombo P. et al. Prognostic and clinical correlates of angiographically diffuse nonobstructive coronary lesions // Heart. - 2003. - Vol. 89. - P. 1009-1013.
Mark D.B., Nelson C.L., Califf R.M. et al. Continuing evolution of therapy for coronary artery disease.
Initial results from the era of coronary angioplasty // Circulation. - 1994. - Vol. 89. - P. 2015-2025.
20th Bethesda Conference. Insurability and employability of the patient with ischemic heart disease. October 3-4, 1988 // J. Am. Coll. Cardiol. - 1989. - Vol. 14. - P. 1004-1044.
Haustein K.O. What can we do in secondary prevention of cigarette smoking? // Eur. J. Cardiovasc. Prev. Rehabil. - 2003. - Vol. 10. - P. 476-485.
US Department of Health and Human Services. The health consequences of smoking: a report of the Surgeon General. Available at: http:// surgeongeneral.gov/library/smokingconsequences/ Washington,
DC. - 2004.
Ambrose J.A., Barua R.S. The pathophysiology of cigarette smoking and cardiovascular disease. An update // J. Am. Coll. Cardiol. - 2004. - Vol. 43. - P. 1731-1737.
Hung J., Lam J.Y., Lacoste L. et al. Cigarette smoking acutely increases platelet thrombus formation in patients with coronary artery disease taking aspirin // Circulation. - 1995. - Vol. 92. - P. 2432-2436.
US Department of Health and Human Services. The Health Benefits of Smoking Cessation. Washington, DC: US Department of Health and Human Services. - 1990.
Tzivoni D., Keren A., Meyler S. et al. Cardiovascular safety of transdermal nicotine patches in patients with coronary artery disease who try to quit smoking // Cardiovasc. Drugs Ther. - 1998. - Vol. 12. - P. 239244.
Eisenberg M.J., Filion K.B., Yavin D. et al. Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials // CMAJ. - 2008. - Vol. 179. - P. 135-144.
Kris-Etherton P.M., Harris W.S., Appel L.J. Fish consumption, fish oil, omega-3. fatty acids, and cardiovascular disease // Arterioscler. Thromb. Vasc. Biol. - 2003. - Vol. 23: e20-e30.
Mead A., Atkinson G., Albin D. et al. Dietetic guidelines on food and nutrition in the secondary prevention of cardiovascular disease evidence from systematic reviews of randomized controlled trials (second update, January 2006) // J. Hum. Nutr. Diet. - 2006. - Vol. 19. - P. 401-419.
Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts). European guidelines on cardiovascular disease prevention in clinical practice: executive summary // Eur .Heart J. - 2007. - Vol. 28. - P. 2375-2414.
GISSI Prevenzione Investigators. Dietary supplementation with n-3. polyunsaturated fatty acids and vitamin E after myocardial infarction: results from the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravivvenza nell’Infarto miocardico // Lancet. - 1999. - Vol. 54. - P. 447-455.
Hooper L., Thompson R.L., Harrison R.A. et al. Risks and benefits of omega 3. fats for mortality, cardiovascular disease, and cancer: systematic review // BMJ. - 2006. - Vol. 332. - P. 752-760.
Rejeski W., Brawley L.R., Ambrosius W.T. et al. Older adults with chronic disease: benefits of group- mediated counseling in the promotion of physically active lifestyles // Health Physiol. - 2003. - Vol. 22. - P. 414-423.
Hammermeister K.E., DeRouen T.A., Dodge H.T. Variables predictive of survival in patients with coronary disease. Selection by univariate and multivariate analyses from the clinical, electrocardiographic, exercise, arteriographic, and quantitative angiographic evaluations // Circulation. - 1979. - Vol. 59. - P. 421-430.
Taylor R.S., Brown A., Ebrahim S. et al. Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials // Am. J. Med. - 2004. - Vol. 116. - P. 682-692.
Shaw K., O’Rourke P., Del Mar C. et al. Psychological interventions for overweight or obesity // Cochrane Database Syst. Rev. - 2005. - Vol. 2: CD003818.
Wing R., Tate D.F., Gorin A.A. et al. A self-regulation program for maintenance of weight loss // N Engl. J. Med. - 2006. - Vol. 355. - P. 1563-1571.
Fox K.M., Thadani U., Ma P.T. et al. Sildenafil citrate does not reduce exercise tolerance in men with erectile dysfunction and chronic stable angina // Eur. Heart J. - 2003. - Vol. 24. - P. 2206-2212.
Arruda-Olson A.M., Mahoney D.W., Nehra A. et al. Cardiovascular effects of sildenafil during exercise in men with known or probable coronary artery disease // JAMA. - 2002. - Vol. 287. - P. 719-725.
Baigent C., Keech A., Kearney P.M. et al. Cholesterol Treatment Trialists’ (CTT) Collaborators. Efficacy and safety of cholesterollowering treatment: prospective meta-analysis of data from 90,056. participants in 14. randomised trials of statins // Lancet. - 2005. - Vol. 366. - P. 1267-1278.
Cannon C.P., Braunwald E., McCabe C.H. et al. Comparison of intensive and moderate lipid lowering with statins after acute coronary syndromes // N. Engl. J. Med. - 2004. - Vol. 350. - P. 495-504.
Gotto A.M., Amarenco P, Assman G., et al. Dyslipedemia and Coronary Heart Disease, 3rd edn, 2003. New York: International Lipid Information Bureau.
Josan K., Majumdar S.R., McAlister F.A. The efficacy and safety of intensive statin therapy: a metaanalysis of randomized trials //CMAJ. - 2008. - Vol. 178. - P. 576-584.
Rubins H.B., Robins S.J., Collins D. et al. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of highdensity lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group // N. Engl. J. Med. - 1999. - Vol. 341. - P. 410-418.
The BIP Study Group. Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease. The Bezafibrate Infarction Prevention (BIP) Study // Circulation. - 2000. - Vol. 102. - P. 21-27.
Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 5963. people with diabetes: a randomised controlled trial // Lancet. - 2003. - Vol. 361. - P. 2005-2006.
Luscher T.F., Creager M.A., Beckman J.A. et al. Diabetes and vascular disease // Circulation. - 2003. - Vol. 108. - P. 1655-1661.
Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61. prospective studies // Lancet. - 2002. - Vol. 360. - P. 1903-1913.
Patrono C., Coller B., FitzGerald G.A. et al. Platelet-active // Drugs: the relationships among dose, effectiveness, and side effects: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy // Chest. - 2004. - Vol. 126. - P. 234S-264S.
Antithrombotic Trialists’ Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients // Br. Med. J. -
- Vol. 324. - P. 71-86.
The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Guidelines on the management of stable angina pectoris: executive summary // Eur. Heart J. - 2006. - Vol. 27. - P. 1341-1381.
Juul-Moller S., Edvardsson N., Jahnmatz B. et al. Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris. The Swedish Angina Pectoris Aspirin Trial (SAPAT) Group // Lancet. - 1992. - Vol. 340. - P. 1421-1425.
Sudlow C., Baigent C. The adverse effects of different doses of aspirin: a systematic review of randomised trials and observational studies (Abstract) // Stroke. - 2000. - Vol. 31. - P. 2869.
Weil J, Colin-Jones D, Langman M, et al. Prophylactic aspirin and risk of peptic ulcer bleeding // BMJ. - 1995. - Vol. 310. - P. 827-830.
Chan F.K., Ching J.Y., Hung L.C. et al. Clopidogrel vs. aspirin and esomeprazole to prevent recurrent ulcer bleeding // N. Engl. J. Med. - 2005. - Vol. 352. - P. 238-244.
Patrono C. Aspirin resistance: definition, mechanisms and clinical read-outs // J. Thromb. Haemost. -
- Vol. 1. - P. 1710-1713.
CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) // Lancet. - 1996. - Vol. 348. - P. 1329-1339.
Saw J., Brennan D.M., Steinhubl S.R. et al. - CHARISMA Investigators. Lack of evidence of a clopidogrel- statin interaction in the CHARISMA trial // J. Am. Coll. Cardiol. - 2007. - Vol. 50. - P. 291-295.
Andreotti F., Testa L., Biondi-Zoccai G.G. et al. Aspirin plus warfarin compared to aspirin alone after acute coronary syndromes: an updated and comprehensive meta-analysis of 25,307. patients // Eur.
Heart J. - 2006. - Vol. 27. - P. 519-526.
Karjalainen P.P., Porela P., Ylitalo A. et al. Safety and efficacy of combined antiplatelet-warfarin therapy after coronary stenting // Eur. Heart J. - 2007. - Vol. 28. - P. 726-732.
Yusuf S., Wittes J., Friedman L. Overview of results of randomized clinical trials in heart disease. I. Treatments following myocardial infarction // JAMA. - 1988. - Vol. 260. - P. 2088-2093.
Freemantle N., Cleland J., Young P. et al. Blockade after myocardial infarction: systematic review of meta regression analysis // Br. Med. J. - 1999. - Vol. 318. - P. 1730-1737.
Rehnqvist N., Hjemdahl P., Billing E. et al. Effects of metoprolol vs. verapamil in patients with stable angina pectoris. The Angina Prognosis Study in Stockholm (APSIS) // Eur. Heart J. - 1996. - Vol. 17. - P. 76-81.
Dargie H.J., Ford I., Fox K.M. Total Ischaemic Burden European Trial (TIBET). Effects of ischaemia and treatment with atenolol, nifedipine SR and their combination on outcome in patients with chronic stable angina. The TIBET Study Group // Eur. Heart J. - 1996. - Vol. 17. - P. 104-112.
Pepine C.J, Cohn PF, Deedwania PC, et al. Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life. The Atenolol Silent Ischemia Study (ASIST) // Circulation. - 1994. - Vol. 90. - P. 762-768.
Brophy J.M., Joseph L., Rouleau J.L. Beta-blockers in congestive heart failure. A Bayesian meta-analysis // Ann. Intern. Med. - 2001. - Vol. 134. - P. 550-560.
The Danish Verapamil Infarction Trial II-DAVIT II Effect of verapamil on mortality and major events after acute myocardial infarction // Am. J. Cardiol. - 1990. - Vol. 66. - P. 779-785.
Pepine C.J., Hanberg E.M., Cooper-DeHoff R.M. et al. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease // JAMA. - 2003. - Vol. 290. - P. 2805-2860.
The Multicenter Diltiazem Postinfarction Trial Research Group. The effect of diltiazem on mortality and reinfarction after myocardial infarction // N. Engl. J. Med. - 1988. - Vol. 319. - P. 385-392.
Boden W.E., Gilst W.H., Scheldewaert RG, et al. Diltiazem in acute myocardial infarction treated with thrombolytic agents: a randomised placebo-controlled trial // Lancet. - 2000. - Vol. 335. - P. 1751-1756.
Poole-Wilson P.A., Lubsen J., Kirwan B.A. et al. Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trial // Lancet. - 2004. - Vol. 364. - P. 849-857.
Nissen S.E., Tuzcu E.M., Libby P. et al. Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial // JAMA. - 2004. - Vol. 292. - P. 2217-2225.
Rosenson, R.S. Modulating atherosclerosis through inhibition or blockade of angiotensin // Clin. Cardiol. -
- Vol. 26. - P. 305-311.
Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients // N. Engl. J. Med. - 2000. - Vol. 342. - P. 145-153.
European Trial on Reduction of Cardiac Events with Perindopril in Stable Coronary Artery Disease Investigators. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study) // Lancet. - 2003. - Vol. 362. - P. 782-788.
Braunwald E., Domanski M.J., Fowler S.E. et al. Angiotensin-converting-enzyme inhibition in stable coronary artery disease. The PEACE trial investigators // N. Engl. J. Med. - 2004. - Vol. 351. - P. 20582117.
ONTARGET Investigators, Yusuf S., Teo K.K., Pogue J,. et al. Telmisartan, ramipril, or both in patients at high risk for vascular events // N. Engl. J. Med. - 2008. - Vol. 358. - P. 1547-1559.
Parker JO. Nitrate tolerance // Eur. J. Clin. Pharmacol. - 1990. - Vol. 38: S21-S25.
Thadani U. Medical therapy of stable angina pectoris // Cardiol. Clin. - 1991. - Vol. 9. - P. 73-87.
Thadani U. Treatment of stable angina // Curr. Opin. Cardiol. - 1999. - Vol. 14. - P. 349-358.
Bakris G.L., Fonseca V., Katholi R.E. et al. Metabolic effects of carvedilol vs metoprolol in patients with type 2. diabetes mellitus and hypertension // JAMA. - 2004. - Vol. 292. - P. 2227-2236.
Hjemdahl P., Wiklund I.K. Quality of life on antihypertensive drug therapy scientific end-point or marketing exercise? // J. Hypertens. - 1992. - Vol. 10. - P. 1437-1446.
Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina) ACC/AHA 2002. guideline update for the management of patients with chronic stable angina- summary article: a report of the American College of Cardiology/American Heart Association // J. Am.
Coll. Cardiol. - 2003. - Vol. 41. - P. 159-168.
Savonitto S., Ardissino D. Selection of drug therapy in stable angina pectoris // Cardiovasc. Drugs Ther. -
- Vol. 12. - P. 197-210.
Deanfield J.E., Detry J.M., Lichtlen P.R. et al. Amlodipine reduces transient myocardial ischemia in patients with coronary artery disease: double-blind Circadian Anti-Ischemia Program in Europe (CAPE Trial) // J. Am. Coll. Cardiol. - 1994. - Vol. 24. - P. 1460-1467.
Ardissino D., Savonitto S., Egstrup K. et al. Selection of medical treatment in stable angina pectoris: results of the International Multicenter Angina Exercise (IMAGE) Study // J. Am. Coll. Cardiol. - 1995. - Vol. 25. - P. 1516-1521.
Forslund L., Hjemdahl P., Held C. et al. Prognostic implications of results from exercise testing in patients with chronic stable angina pectoris treated with metoprolol or verapamil. A report from the Angina Prognosis Study In Stockholm (APSIS) // Eur. Heart J. - 2000. - Vol. 21. - P. 901-910.
Arnim T.V. Medical treatment to reduce total ischaemic burden: total ischaemic burden bisoprolol study (TIBBS), a multicenter trial comparing bisoprolol and nifedipine. The TIBBS Investigators // J. Am. Coll. Cardiol. - 1995. - Vol. 25. - P. 231-238.
Fox K.M., Mulcahy D., Findlay I. et al. The Total Ischaemic Burden European Trial (TIBET). Effects of atenolol, nifedipine SR and their combination on the exercise test and the total ischaemic burden in 608. patients with stable angina. The TIBET Study Group // Eur. Heart J. - 1996. - Vol. 17. - P. 96-103.
Heidenreich P.A., McDonald K.M., Hastie T. et al. Meta-analysis of trials comparing beta-blockers, calcium antagonists, and nitrates for stable angina // JAMA. - 1999. - Vol. 281. - P. 1927-1936.
Markham A., Plosker G.L., Goa K.L. Nicorandil. An updated review of its use in ischaemic heart disease with emphasis on its cardioprotective effects // Drugs. - 2000. - Vol. 60. - P. 955-974.
The IONA Study Group. Effect of nicorandil on coronary events in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomised trial // Lancet. - 2002. - Vol. 359. - P. 1269-1275.
Fox K., Ford I., Steg P.G. et al. - BEAUTIFUL investigators. Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial // Lancet. - 2008. - Vol. 372. - P. 817-821.
Singh, B.N. Morbidity and mortality in cardiovascular disorders: impact of reduced heart rate // J. Cardiovasc. Pharmacol. Ther. - 2001. - Vol. 6. - P. 313-331.
Borer J.S., Fox K., Jaillon P.G. et al., for the Ivabradine Investigators Group. Anti-anginal and anti- ischaemic effects of ivabradine, an I(f)inhibitor, in stable angina: a randomized, double-blind, multicentered, placebo-controlled trial // Circulation. - 2003. - Vol. 107. - P. 817-823.
Tardif J.C., Ponikowski P., Kahan T. et al. - ASSOCIATE Study Investigators. Efficacy of the I(f) current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4-month, randomized, placebo-controlled trial // Eur. Heart. J. - 2009. - Vol. 30. - P. 540-548.
O’Rourke, R.A. Measuring antianginal drug efficacy using exercise testing for chronic angina: improved exercise performance with ranolazine, a pFox inhibitor // Curr. Probl. Cardiol. - 2002. - Vol. 27. - P. 521556.
Chaitman B.R., Skettino S.L., Parker J.O. for the Monotherapy Assesment of Ranolazine in Stable Angina (MARISA) Investigators. Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with severe chronic angina // J. Am. Coll. Cardiol. - 2004. - Vol. 43. - P. 1375-1382.
Chaitman B.R., Pepine C.J., Parker J.O., for the Combination Assessment of Ranolazine In Stable Angina (CARISA) Investigators. Effects of ranolazine with atenolol, amlodipine, or diltiazem or exercise tolerance and angina frequency in patients with severe chronic angina. A randomized controlled trial // JAMA. - 2004. - Vol. 291. - P. 309-316.
Stone P.H., Gratsiansky N.A., Blokhin A. et al. - ERICA Investigators. Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial // J. Am. Coll. Cardiol. - 2006. - Vol. 48. - P. 566-575.
Wilson S.R., Scirica B.M., Braunwald E. et al. Efficacy of ranolazine in patients with chronic angina observations from the randomized, double-blind, placebo-controlled MERLIN-TIMI (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Segment Elevation Acute Coronary Syndromes) 36. Trial // J. Am. Coll. Cardiol. - 2009. - Vol. 53. - P. 1510-1516.
Juni P., Nartey L., Reichenbach S. et al. Risk of cardiovascular events and rofecoxib: cumulative metaanalysis // Lancet. - 2004. - Vol. 364. - P. 2021-2029.
Kearney P.M., Baigent C., Godwin J. et al. Do selective cyclo-oxygenase-2. inhibitors and traditional nonsteroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials // BMJ. - 2006. - Vol. 332. - P. 1302-1308.
Rossouw J.E., Prentice R.L., Manson J.E. et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause // JAMA. - 2007. - Vol. 297. - P. 1465-1477.
Gruntzig A. Transluminal dilatation of coronary-artery stenosis // Lancet. - 1978. - Vol. 1. - P. 263.
Lenzen M.J., Boersma E., Mertrand M.E., et al. Management and outcome of patients with significant coronary artery disease: the EuroHeart Survey on coronary revascularisation // Eur. Heart J. - 2005. - Vol. 26. - P. 1169-1179.
Violaris A.G., Serruys P.W. New technologies in interventional cardiology // Curr. Opin. Cardiol. - 1994. - Vol. 9. - P. 493-502.
Hall P., Nakamura S., Maiello L. et al. A randomized comparison of combined ticlopidine and aspirin therapy versus aspirin therapy alone after successful intravascular ultrasound-guided stent implantation // Circulation. - 1996. - Vol. 93. - P. 215-222.
Brophy J.M., Belisle P., Joseph L. Evidence for use of coronary stents. A hierarchical bayesian metaanalysis // Ann. Intern. Med. - 2003. - Vol. 138. - P. 777-786.
Al Suwaidi J., Holmes D.R. Jr., Salam A.M., et al. Impact of coronary artery stents on mortality and nonfatal myocardial infarction: meta-analysis of randomized trials comparing a strategy of routine stenting with that of balloon angioplasty // Am. Heart J. - 2004. - Vol. 147. - P. 815-822.
Kastrati A. Schomig A., Elezi S. et al. Predictive factors of restenosis after coronary stent placement // J. Am. Coll. Cardiol. - 1997. - Vol. 30. - P. 1428-1436.
Mehran R., Dangas G., Abizaid A.S. et al. Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome // Circulation. - 1999. - Vol. 100. - P. 1872-1878.
Waksman R., Ajani A.E., White R.L. et al. Five-year follow-up after intracoronary gamma radiation therapy for in-stent restenosis // Circulation. - 2004. - Vol. 109. - P. 340-344.
Babapulle M.N., Joseph L., Belisle P. et al. A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stents // Lancet. - 2004. - Vol. 364. - P. 583-591.
Barbato E., Marco J., Wijns W. Direct stenting // Eur. Heart J. - 2003. - Vol. 24. - P. 394-403.
Schofer J., Schluter M., Gershlick A.H. et al. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS) // Lancet. - 2003. - Vol. 362. - P. 1093-1099.
Lemos P.A., Serruys P.W., Domburg RT, et al. Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the ‘real world’: the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry // Circulation. - 2004. - Vol. 109. - P. 190-195.
Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Guidelines for percutaneous coronary interventions // Eur. Heart J. - 2005. - Vol. 26. - P. 804-847.
Stone G.W., Ellis S.G., Colombo A, et al. Offsetting impact of thrombosis and restenosis on the occurrence of death and myocardial infarction after paclitaxel-eluting and bare metal stent implantation // Circulation. - 2007. - Vol. 115. - P. 2842-2847.
James S.K., Stenestrand U., Lindback J. et al. Long-term safety and efficacy of drug-eluting versus bare- metal stents in Sweden // N. Engl. J. Med. - 2009. - Vol. 360. - P. 1933-1945.
Patti G., Colonna G., Pasceri V. et al. Randomized trial of high loading dose of clopidogrel for reduction of periprocedural myocardial infarction in patients undergoing coronary intervention: results from the ARMYDA-2. (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) study // Circulation. - 2005. - Vol. 111. - P. 2099-2106.
Kastrati A., Mehilli J., Schuhlen H. et al. A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel // N. Engl. J. Med. - 2004. - Vol. 350. - P. 232-238.
Montalescot G., White H.D., Gallo R. et al. - STEEPLE Investigators. Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention // N. Engl. J. Med. - 2006. - Vol. 355. - P. 10061017.
Mahaffey K.W., Lewis B.E., Wildermann N.M. et al. The anticoagulant therapy with bivalirudin to assist in the performance of percutaneous coronary intervention in patients with heparin-induced thrombocytopenia (ATBAT) study: main results // J. Invasive Cardiol. - 2003. - Vol. 15. - P. 611-616.
Parisi A.F., Folland E.D., Hartigan P. A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. Veterans Affairs ACME Investigators // N. Engl. J. Med. - 1992. - Vol. 326. - P. 10-16.
RITA-2 trial participants. Coronary angioplasty versus medical therapy for angina: the second Randomised Intervention Treatment of Angina (RITA-2) trial // Lancet. - 1997. - Vol. 350. - P. 461-468.
Pitt B., Waters D., Brown W.V. et al. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators // N. Engl.
J. Med. - 1999. - Vol. 341. - P. 70-76.
Katritsis D.G., Ioannidis J.P. Percutaneous coronary intervention versus conservative therapy in nonacute coronary artery disease: a meta-analysis // Circulation. - 2005. - Vol. 111. - P. 2906-2912.
Boden W.E., O’Rourke R.A., Teo K.K. et al. - COURAGE Trial Research Group. Optimal medical therapy with or without PCI for stable coronary disease // N. Engl. J. Med. - 2007. - Vol. 356. - P. 1503-1516.
Schomig A., Mehilli J., de Waha A. et al. A meta-analysis of 17. randomized trials of a percutaneous coronary intervention-based strategy in patients with stable coronary artery disease // J. Am. Coll.
Cardiol. - 2008. - Vol. 52. - P. 894-904.
Bech G.J., Bruyne B., Bonnier H.J. et al. Long-term follow-up after deferral of percutaneous transluminal coronary angioplasty of intermediate stenosis on the basis of coronary pressure measurement // J. Am. Coll. Cardiol. - 1998. - Vol. 31. - P. 841-847.
Favaloro R.G. Saphenous vein graft in the surgical treatment of coronary artery disease. Operative technique // J. Thorac. Cardiovasc. Surg. - 1969. - Vol. 58. - P. 178-185.
Barner H.B., Standeven J.W., Reese J. Twelve-year experience with internal mammary artery for coronary artery bypass // J. Thorac. Cardiovasc. Surg. - 1985. - Vol. 90. - P. 668-675.
Cameron A., Davis K.B., Green G. et al. Coronary bypass surgery with internal-thoracic-artery grafts- effects on survival over a 15-year period // N. Engl. J. Med. - 1996. - Vol. 334. - P. 216-219.
Thourani V.H., Weintraub W.S., Stein B. Influence of diabetes mellitus on early and late outcome after coronary artery bypass grafting // Ann. Thorac. Surg. - 1999. - Vol. 67. - P. 1045-1052.
Lytle B.W., Blackstone E.H,. Loop F.D. Two internal thoracic artery grafts are better than one // J. Thorac. Cardiovasc. Surg. - 1999. - Vol. 117. - P. 855-872.
Taggart D.P., D’Amico R., Altman DG. Effect of arterial revascularisation on survival: a systematic review of studies comparing bilateral and single internal mammary arteries // Lancet. - 2003. - Vol. 361. - P. 615616.
Buxton B.F., Raman J.S., Ruengsakulrach P. Radial patency and clinical outcomes: five-year interim results of a randomized trial // J. Thorac. Cardiovasc. Surg. - 2003. - Vol. 125. - P. 1363-1371.
Khot U.N., Friedman D.T, Pettersson G. et al. Radial artery bypass grafts have an increased occurrence of angiographically severe stenosis and occlusion compared with left internal mammary arteries and saphenous vein grafts // Circulation. - 2004. - Vol. 109. - P. 2086-2091.
Dijk D., Nierich A.P., Jansen E.W. Early outcome after off-pump versus on-pump coronary bypass surgery: results from a randomized study // Circulation. - 2002. - Vol. 104. - P. 1761-1766.
Angelini G.D., Taylor F.C., Reeves B.C. et al. Early and mid-term outcome after off-pump and on-pump surgery in Beating Heart Against Cardioplegic Arrest Studies (BHACAS 1. and 2): a pooled analysis of two randomized controlled trials // Lancet. - 2002. - Vol. 359. - P. 1194-1199.
Parolari A., Alamanni F., Cannata A. Off-pump versus on-pump coronary artery bypass: a meta-analysis of currently available randomized trials // Ann. Thorac. Surg. - 2003. - Vol. 76. - P. 37-40.
Khan N.E., De Souza A., Mister R. et al. A randomized comparison of off-pump and on-pump multivessel coronary-artery bypass surgery // N. Engl. J. Med. - 2004. - Vol. 350. - P. 21-28.
Hannan E.L., Wu C., Smith C.R. et al. Off-pump versus on-pump coronary artery bypass graft surgery: differences in short-term outcomes and in long-term mortality and need for subsequent revascularization // Circulation. - 2007. - Vol. 116. - P. 1145-1152.
Brener S.J., Loop F.D., Lytle B.W. et al. A profile of candidates for repeat myocardial revascularisation: implications for selection of treatment // J. Thorac. Cardiovasc. Surg. - 1997. - Vol. 114. - P. 153-161.
Lytle B.W., Loop F.D., Taylor P.C. et al. The effect of coronary reoperation on the survival of patients with stenoses in saphenous vein bypass grafts to coronary arteries // J. Thorac. Cardiovasc. Surg. - 1993. - Vol. 105. - P. 605-612.
Rihal C.S., Raco D.L., Gersh B.J. et al. Indications for coronary artery bypass surgery and percutaneous coronary intervention in chronic stable angina: review of the evidence and methodological considerations // Circulation. - 2003. - Vol. 108. - P. 2439-2445.
Yusuf S., Zucker D., Peduzzi P. et al. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration // Lancet. - 1994. - Vol. 344. - P. 563-570.
Jones R.H. Kesler K., Phillips H.R. et al. Long-term survival benefits of coronary artery bypass grafting and percutaneous transluminal angioplasty in patients with coronary artery disease // J. Thorac. Cardiovasc. Surg. - 1996. - Vol. 111. - P. 1013-1025.
The Veterans Administration Coronary Artery Bypass Surgery Cooperative Study Group: Eleven-year survival in the Veterans Administration randomized trial coronary bypass surgery for stable angina // N. Engl. J. Med. - 1984. - Vol. 311. - P. 1333.
Varnauskas E. Survival, myocardial infarction, and employment status in a prospective randomized study of coronary bypass surgery // Circulation. - 1985. - Vol. 72. - P. 90.
Passamani E., Davis K.B., Gilliespie M.J. et al. A randomized trial of coronary artery bypass syrgery. Survival of patients with a low ejection fraction // N. Engl. J. Med. - 1985. - Vol. 312. - P. 1665.
European Coronary Surgery Study Group. Long-term results of prospective randomised study of coronary artery bypass surgery in stable angina pectoris // Lancet. - 1982. - Vol. 2. - P. 1173-1180.
Aaa Myocardial infarction and mortality in the coronary artery surgery study (CASS) randomized trial // N. Engl. J. Med. - 1984. - Vol. 310. - P. 750-758.
Davies R.F., Goldberg A.D., Forman S. et al. Asymptomatic Cardiac Ischemia Pilot (ACIP) study 2 year follow-up: outcomes of patients randomized to initial strategies of medical therapy versus revascularization // Circulation. - 1997. - Vol. 95. - P. 2037-2043.
Pfisterer M.E., Kiowski W., Brunner H. et al. Long-term benefit of 1-year amiodarone treatment for persistent complex ventricular arrhythmias after myocardial infarction // Circulation. - 1993. - Vol. 87. - P. 309-311.
Hueb W.A., Bellotti G., de Oliveira S.A. et al. The Medicine, Angioplasty or Surgery Study (MASS): a prospective, randomized trial of medical therapy, balloon angioplasty or bypass surgery for single proximal left anterior descending artery stenoses // J. Am. Coll. Cardiol. - 1995. - Vol. 26. - P. 1600-1605.
Cameron A.A., Davis K.B., Rogers W.J. Recurrence of angina after coronary artery bypass surgery: predictors and prognosis (CASS Registry). Coronary Artery Surgery Study // J. Am. Coll. Cardiol. - 1995. - Vol. 26. - P. 895-599.
Bell M.R., Gersh B.J., Schaff H.V. Effect of completeness of revascularisation on long-term outco